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Abstract
Studies in Saccharomyces cerevisiae show that many proteins influence cellular survival upon exposure to DNA damaging
agents. We hypothesized that human orthologs of these S. cerevisiae proteins would also be required for cellular survival
after treatment with DNA damaging agents. For this purpose, human homologs of S. cerevisiae proteins were identified and
mapped onto the human protein-protein interaction network. The resulting human network was highly modular and a series
of selection rules were implemented to identify 45 candidates for human toxicity-modulating proteins. The corresponding
transcripts were targeted by RNA interference in human cells. The cell lines with depleted target expression were
challenged with three DNA damaging agents: the alkylating agents MMS and 4-NQO, and the oxidizing agent t-BuOOH. A
comparison of the survival revealed that the majority (74%) of proteins conferred either sensitivity or resistance. The
identified human toxicity-modulating proteins represent a variety of biological functions: autophagy, chromatin
modifications, RNA and protein metabolism, and telomere maintenance. Further studies revealed that MMS-induced
autophagy increase the survival of cells treated with DNA damaging agents. In summary, we show that damage recovery
proteins in humans can be identified through homology to S. cerevisiae and that many of the same pathways are
represented among the toxicity modulators.
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Introduction
Sensing, signaling and repair of DNA damage requires many
proteins [1] and depletion of any one of these proteins may affect
cellular survival after DNA damage. DNA damaging agents, from
both endogenous and exogenous sources, constantly challenge
genome integrity, causing mutations, permanent cell cycle arrest
and cell death. The two latter endpoints can be exploited for
therapeutic purposes. For example, a common class of cancer
chemotherapy agents are DNA damaging agents that act by
alkylation, as represented by the drugs Temozolomide and
Carmustine (1,3-bis(2-chloroethyl)-1-nitrosourea, BCNU) [2,3].
Other alkylating agents include the extensively studied model
agents methyl methanesulfonate (MMS) and 4-nitroquinoline-N-
oxide (4-NQO) that have been used to explore the DNA damage
responses of cells and organisms (reviewed in [4]). The simple SN2
alkylating agent MMS attacks DNA, forming products that
include 7-methylguanine and the highly toxic 3-methyladenine
[5]. These lesions can be efficiently removed by DNA glycosylases
like AAG/MPG in mammals to initiate the base excision pathway
[6]. Damage induced by the bulky alkylating agent 4-NQO
requires a more complex arsenal of repair capacities [7,8,9]. The
large DNA base adducts formed by the metabolically activated 4-
NQO stall both transcription and replication, as does 3-
methyladenine (3MeA), but in contrast, 4-NQO induced lesions
are not necessarily as toxic as 3MeA [10]. Many of the 4-NQO
induced lesions require nucleotide excision repair to be resolved
[9]. Also, in the process of activation, 4-NQO metabolism
generates reactive oxygen species, causing oxidative damage to
cellular components. Another pro-oxidant is the oxidizing agent
tert-butyl hydroperoxide (t-BuOOH), which has many effects on
cell metabolism [11].
All of the mentioned DNA damaging agents have been shown
to modulate the expression of many genes, and cells lacking a wide
variety of proteins show aberrant responses to DNA damage
[12,13,14,15,16,17,18,19,20,21,22,23,24,25]. Indeed, recent ge-
nome-wide siRNA screens in human cells have revealed many
unexpected pathways involved in maintaining genome stability
[19,22,23]. In budding yeast, extensive studies of deletion mutants
have revealed that approximately 30% of the genes affect recovery
after damage with alkylating agents. Previous studies from our
group determined yeast survival in libraries of gene deletion
mutants after exposure to four DNA damaging agents (MMS, 4-
NQO, t-BuOOH and UV). Distinct toxicity profiles were
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identified for each agent, and surprisingly, very few gene deletion
strains were sensitive to all four agents. Similar screens of toxicity-
modulating proteins have been conducted for MMS in Drosophila
[26] and for ionizing radiation in C. elegans [27], showing
comparable results. The toxicity-modulating proteins represent
a variety of biological functions and biochemical pathways. Apart
from proteins involved in stress signaling, cell cycle control, DNA
repair and cell death, functions such as transcription, vesicle
transport, protein and RNA metabolism, and telomere mainte-
nance also affect recovery after exposure to DNA damaging
agents. However, the direct role of these processes in damage
recovery remains largely unknown.
In this study, we aimed to identify novel pathways needed for
human cells to recover from exposure to DNA damaging agents.
We hypothesized that the yeast data combined with the human
protein interactome could be used to pinpoint human proteins
needed for recovery, thus identifying novel damage response
pathways in humans. Based on the results from S. cerevisiae [13], we
used computational techniques to identify human protein
candidates of toxicity modulation. 45 human proteins, spanning
the human pathways identified as toxicity-modulating in S.
cerevisiae, were tested for their role in the recovery of human cells
after damage. We found that 74% of the proteins tested modulated
the survival of human cells.
Results
Identification of human homologs of toxicity-modulating
yeast proteins
The aim of this study was to determine whether the human
homologs of toxicity-modulating proteins in yeast, spanning a wide
range of cellular functions, also play roles in the damage response
of human cells. First, human-yeast protein homologs were
identified based on amino acid sequence similarity. Toxicity-
modulating proteins were selected from [13]. Two public
databases, Ensembl and Inparanoid, were used to identify 1,368
homologs of the 4,733 proteins represented in the S. cerevisiae gene
deletion library. Of these, 646 human proteins were identified as
homologous to yeast proteins with toxicity-modulating properties
for at least one of the four DNA damaging agents used in the yeast
study. The homologs were projected onto a human protein-
protein interaction network previously described [28]. Surprising-
ly, 44% of the nodes, representing 284 proteins, were connected in
one large connected component (p,1610216, permutation test),
indicating that although the proteins are involved in disparate
functions, a large proportion of them are connected by protein-
protein interactions (Figure 1, an interactive version at http://
www.bionut.ki.se/users/pesv/MIT/fig1.html). In the large con-
nected component of the interactome, numerous biological
categories are represented, including DNA repair, stress signaling,
vesicle transport, chromatin modification, plus lipid, protein and
RNA metabolism. The network is highly modular and most of the
functional categories represented in yeast are also represented in
the human network, with the exception of telomere maintenance
(Tables S1a and S1b). Telomere stability is maintained by non-
homologous proteins in S. cerevisiae and mammals and therefore
a group of telomere-specific human proteins were queried
separately.
Selection of putative toxicity-modulating human
proteins
To reduce the number of targets from all the human homologs
of toxicity-modulating yeast proteins, a set of selection rules was
implemented. In the previous study of yeast proteins in a library of
deletion strains [13], only 28 strains were sensitive to all four of the
tested DNA damaging agents. Twelve of the 28 proteins had
human homologs and were included in this screen; these proteins
display heterogeneity in cellular functions (Table S2). Additional
targets were selected from the large interconnected sub-network.
Proteins with already established roles in DNA repair or cell cycle
control were excluded, as were ribosomal proteins. Preference was
given to proteins with only one human homolog to a specific yeast
protein, and to proteins with several protein-protein interactions.
In addition, genes had to be expressed at reasonable levels in
human cells as measured in a previous study [29]. We also gave
preference to proteins that were among the highly represented
categories in yeast, such as transcription, chromatin remodeling,
vesicle transport and protein/mRNA degradation. In light of the
involvement of telomere maintenance among the toxicity-modu-
lating yeast proteins, four proteins in the shelterin complex were
also selected since the shelterin complex is specific for telomere
maintenance in mammalian cells. A brief summary of the 45
selected proteins, including a description of functions, GO terms
and yeast homologs and their sensitivity, can be found in Table S2.
Efficient reduction of mRNA levels in 293T cells
RNA interference was used to deplete the transcript levels of the
selected targets in human cells. Stable clonal cell lines were created
after lentiviral infection of shRNAs targeting the mRNA of
selected genes. We used the adherent embryonic kidney cell lines
293T as the parental cell line since these cells readily and stably
express foreign DNA. For 35 gene targets we achieved a reasonable
knock-down effect (,60% residual mRNA level compared to
controls) in the 293T background (Figure 2A).
The large majority of selected homologs are toxicity-
modulating in human cells
To test whether deficiency for the targeted proteins resulted in
altered sensitivity to DNA damaging agents, the cells with reduced
levels of the target mRNA were exposed to three different
damaging agents at equitoxic doses: the alkylating agents MMS
and 4-NQO and the oxidizing agent t-BuOOH. The cell lines
were always compared to control experiments performed
contemporaneously. The variation between days was minimal,
as determined by the repeated survival data of the control cell line
expressing an shRNA construct targeting a sequence not present
in the human genome (data not shown). To account for off-target
effects, four non-silenced cell lines expressing an shRNA construct
were tested for survival after treatment with the damaging agents.
These non-silenced cell lines expressed target shRNA against
RNASEH2A, TBL1XR1, AP3D1 and a non-silencing clone of
ATP6V1F had no significant effect on the target gene expression
(.60% residual levels of target RNA, Figure S1A). The sensitivity
range of these cell lines together with the range of cells expressing
shRNA targeting a sequence not present in the human genome
were set as the detection limits of this screen (Figure S1B–C, grey
and black lines). The survival data of the cell lines with confirmed
targeted gene silencing is summarized in a heatmap (Figure 2B).
XPA-deficient cells were included as a positive control. XPA is
a DNA repair protein know to be important for the repair of UV-
induced lesions [30]. Here we show that lack of XPA lead to
a specific reduction in survival after treatment with the UV-
mimetic 4-NQO. In summary, for 34 targets that were not
previously associated with the DNA damage response, we
obtained significant and reproducible results regarding their effect
on sensitivity to three DNA damaging agents. These data show
that reduced transcript levels of 14 of the 34 proteins (41%)
conferred high (.25% different from WT) or moderate (20–25%
Novel Human Damage Recovery Proteins
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Figure 1. Human interaction network shows high connectivity among putative human toxicity-modulating proteins homologous to
toxicity-modulating proteins in yeast. The largest connected component of the human interactome selected from yeast orthologs being
required for damage recovery after treatment with MMS, 4NQO, t-BuOOH and UV [13]. The circles represent: red – proteins with toxicity-modulating
yeast homologs targeted for silencing in this study; grey – proteins with toxicity-modulating yeast homologs not targeted in this study; blue –
proteins with non-toxicity-modulating yeast homologs targeted in this study; green –proteins specific for mammalian telomere maintenance
targeted in this study. An interactive version of this figure is available at http://www.bionut.ki.se/users/pesv/MIT/fig1.html.
doi:10.1371/journal.pone.0037368.g001
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different from WT) sensitivity to DNA damaging agents in cells.
Surprisingly, as target proteins were selected based on the
sensitivity of yeast deletion mutants, 11 (32%) of the human cell
lines showed high or moderate resistance to DNA damaging
agents. In total, 19 of the 34 proteins (56%) showed high (.25%
different from WT) toxicity-modulation (see Material and
Methods section for details). Six additional proteins showed
moderate (20–25% different from WT) toxicity-modulation
(FBXL2, POT1, PEX10, HDAC6, PRPS2, and LSM1), bringing
the total percentage of toxicity-modulating proteins in our
selection to 74%.
A random selection of human proteins contains a low
proportion of toxicity-modulating proteins
Given that 74% of the targeted proteins caused a toxicity-
modulating phenotype, we then sought to estimate what would be
found by random chance. We hypothesized that human deficiency
of homologs of yeast proteins that did not modulate toxicity in
yeast would likewise not result in sensitivity changes to the DNA
damaging agents in human cells. To test this hypothesis, we
identified the proteins with no evidence of toxicity-modulation in
yeast [13]. Out of the 724 yeast-human homologs of non-toxicity-
modulators, 200 genes were expressed in human cell lines [29].
Five of these proteins were selected completely at random:
SLC25A5, AP3D1, ADIPOR1, URM1, RASA1. For four
proteins, reduced mRNA levels (,60%) were achieved. For cell
lines lacking these proteins, the survival after treatment with the
DNA damaging agents was determined. A deficiency for only one
of the four proteins, URM1, resulted in an altered sensitivity
phenotype. URM1 was recently described to affect cellular
recovery after starvation and oxidative stress [31]. Despite the
small number of cell lines tested here, we conclude that 74% of
toxicity-modulating proteins in our screen appears to be different
from the random sampling of proteins (borderline significance,
p = 0.08 (Fischer’s exact test)). Therefore, the selection of yeast-
human homologs seems advantageous in discovering new mam-
malian toxicity-modulating proteins, although we were not able to
predict the direction of the toxicity-modulation, i.e. relative
sensitivity or resistance.
Requirement of autophagy to survive after MMS-induced
damage
The toxicity-modulation results (Figure 2B) revealed that cells
lacking the vesicle proteins ZFYVE20, ATP6V1D and VPS16
became sensitive to MMS, suggesting an involvement of early and
late endosomal pathways in damage recovery. The late endosomal
vesicle transport intersects with the autophagic pathway, and we
set out to characterize the role of autophagy after damage by DNA
damaging agents. During the autophagic process, cellular
components are engulfed in autophagosomes with LC3-molecules
on the surface. These autophagosomes are fused with acidic
lysosomes to form autolysosomes where the engulfed components
are broken down and possibly recycled (Figure 3A). To determine
the significance of autophagy after DNA damage, we studied the
effect of inhibiting autophagy in wild-type 293T cells. A chemical
inhibitor of the early steps of autophagy (3-methyladenine, 3MeA)
and an inhibitor of the late steps (Bafilomycin A1, BA1) were used
(Figure 3A). BA1 inhibits autophagic completion and leads to
accumulation of late autophagic vesicles. Wild-type cells were
incubated in the presence of an autophagy inhibitor two hours
prior to the one hour treatment with the damaging agent. The
survival after MMS was severely diminished by the reduced
autophagy mediated by both inhibitors (Figure 3B), indicating that
autophagy is needed for the cells to recover after MMS exposure.
Significant sensitization of the cells were observed after treatment
with 4-NQO and t-BuOOH, although less pronounced compared
to MMS (Figure S2). This finding indicate a general requirement
for autophagy after cellular treatment with DNA damaging agents
to rescue the exposed cells.
In an attempt to study the dynamics of autophagy induction,
cells were transfected with GFP-tagged LC3 and followed during
6 hours. LC3 accumulates in the autophagosomes [32] and these
GFP-labelled autophagosomes can be visualized as puncta using
a fluorescent microscope. To further study the autophagic flux, we
also followed the progression of autophagy by incubation of the
cells with Lysotracker, which will stain acidic compartments such
as lysosomes and autolysosomes. Cells that contained .5 visible
puncta were scored as autophagic cells (Figure 3C). A subset of the
LC3-positive autophagosomes (stained green) fuse with lysosomes
(red) to make the autolysosomes (yellow), in both untreated and
treated cells. This observation is consistent with previous studies of
293 cells [33,34]. Low frequencies of autophagic cells were found
in the control cultures with and without 3MeA. Cells were treated
with BA1 to inhibit late steps of autophagy and thus trap the cells
with induced but not completed autophagy, or with the known
autophagy-inducer rapamycin. Both treatments induced 3–4-fold
higher levels of autophagic cells. MMS treatment induced
autophagy to the same extent (Figure 3D). Further analysis of
the dose-dependencies of autophagy induction revealed a robust
dose and time response for MMS. After pretreatment of the cells
with inhibitor BA1, the percentage of cells with induced autophagy
did not further increase upon subsequent MMS exposure
(Figure 3E, F).
We then sought to elucidate the autophagy-related role of the
proteins ATP6V1D and ZFYVE20. Cells depleted for ATP6V1D
and ZFYVE20 were sensitive to MMS. Autophagy inhibitor
3MeA further sensitized both depleted cell lines at low loses of
MMS (Figure 4A). The study of LC3 puncta was disadvantaged by
the fact that the cells already expressed GFP to some level and
therefore had a uniform cytoplasmic background of GFP.
However, after transfection with the LC3-GFP construct, cells
with clearly defined puncta within the GFP background could be
scored (Figure 4B). As a consequence of the background GFP-
levels, the percentages of identifiable autophagy-positive cells were
lower in these cells (Figure 4C). The cell lines depleted of
ATP6V1D and ZFYVE20 were both sensitive to MMS, and
neither cell line was able to significantly induce autophagy over
background levels following MMS treatment. Reduced levels of
ATP6V1D lead to an accumulation of autophagosomes, suggest-
ing that ATP6V1D is involved in the late steps of MMS-induced
autophagy, in the clearance of the autophagosomes. However,
reduced levels of ZFYVE20 resulted in a lower percentage of
autophagic cells in the treated cultures, suggesting that ZFYVE20
is involved in the early steps of MMS-induced autophagy, such as
the formation of the autophagosomes.
Damage sensitivity and chromatin remodeling
Many targets in our screen affect the structural status of
chromatin. These include histone modifiers such as a histone
ubiquitin ligase (RNF20) and components of complexes changing
the acetylation status of histones (TADA2A, SIN3A and HDAC6).
TOP3A creates transient single stranded DNA breaks that will
alter the topology of chromatin, and POLR2D is a subunit of
RNA polymerase II. Reduced cellular levels of these proteins lead
to increased (SIN3A, RNF20, TOP3A, POLR2D) or decreased
(TADA2A, HDAC6) survival after 4-NQO exposure compared to
survival of control cells. The bulky lesions induced by 4-NQO
Novel Human Damage Recovery Proteins
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Figure 2. The majority of the selected proteins modulate the recovery after damage from the three compounds MMS, 4-NQO and t-
BuOOH. A) RNA levels of shRNA targeted genes in 293T cells were measured by qRT-PCR and compared to cells infected with non-silencing control
shRNA. B) Survival of cells depleted of target proteins exposed to three DNA damaging agents as revealed by heatmap. The color represents
sensitivity to the damaging agent compared to the cell lines with non-silenced targets. ++ indicate high resistance. + low resistance, 2 high
sensitivity,2 low sensitivity. C) Knock-down of human homologs of non-toxicity modulating proteins in yeast, as measured by qRT-PCR. D) Survival of
cells depleted of human homologs of non-toxicity modulating proteins in yeast. Colors and symbols are the same as in B.
doi:10.1371/journal.pone.0037368.g002
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[7,8] presumably cause conformational changes in chromatin,
possibly explaining the requirement of chromatin modifiers for
survival.
Other proteins and functions
The telomere specific proteins tested in this study (TERF1,
TERF2, ACD and POT1) all resulted in some cellular sensitivity
to MMS when depleted, arguing that the enrichment for the
‘telomere maintenance’ term in the yeast screen is caused by the
need to maintain intact telomeres for survival, in addition to the
fact that the yeast telomere maintenance proteins also have an
active role in DNA repair. RNA degradation was represented in
this study by LSM1, EXOSC10, CDC40 and NCBP2. Depletion
of these proteins led to 4NQO resistance (CDC40 and LSM1) or
no visible phenotype (EXOSC10 and NCBP2). The rest of the
targeted proteins form a mosaic of different known or unknown
functions. Interestingly, the signaling protein CTDNEP1 (the
homolog of yeast Nem1, YHR004C) [35] is one of the few proteins
that lead to cellular sensitivity to t-BuOOH when depleted,
relative to WT. XPA is the only tested protein with a clearly
Figure 3. Response to MMS relies on autophagy. A) Model for induction and inhibition of autophagy. 3-methyladenine (3MeA) inhibits the
formation of autophagosomes and bafiloycin A1 inhibits the acidification of the lysosomes leading to an accumulation of autophagosomes. LC3 is
a marker of autophagosomes, here was tagged with GFP. B) Inhibition of autophagy decreases survival, both with 3MeA and BA1. C) Autophagy as
seen by the formation of LC3-GFP-puncta showing autophagosomes in treated cells (top panel). A subset of the LC3-GFP-puncta co-stain (white
arrows) with the acidic vesicles labeled by Lysotracker Red (white and red arrows) (bottom panel). D) Significant induction of autophagy after MMS
treatment (1.2 mM). E–F) MMS induces autophagy in a dose and time dependent manner, whereas accumulation of autophagosomes by BA1 is not
affected by MMS.
doi:10.1371/journal.pone.0037368.g003
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defined role in DNA repair. It was selected as a positive control as
it is known that cells lacking the nucleotide excision repair
component XPA are sensitive to 4-NQO [36]. We confirmed this
finding, as the cell line deficit in XPA is one of the most 4-NQO
sensitive in this screen.
Discussion
‘DNA damaging agents’ cause damage to numerous cellular
molecules and do not only damage DNA. In response to treatment
with these agents, cells modulate the expression levels of genes in
several different pathways. The results of this study show that
many proteins and pathways are needed for recovery from specific
types of damage. Previously, results from genome-wide RNAi
screens have suggested the involvement of a vast repertoire of
DNA damage recovery proteins. Among these are proteins
involved in mRNA processing, chromatin binding and Charcot
Marie Tooth-disease [19,22,23]. Here, as an alternative to
genome-wide RNAi screens, we have implemented a focused
approach where we take advantage of previous results from model
organisms, such as S. cerevisiae, and extensive knowledge of protein-
protein interactions and interactomes.
Among the human homologs of toxicity-modulating yeast
proteins, 25 of the 34 proteins were found to be toxicity-
modulating in human cells. The three DNA damaging agents,
MMS, 4-NQO and t-BuOOH, revealed distinct toxicity profiles
with proteins specifically conferring resistance or sensitivity to at
least one of the three agents. Deficiency for only one of the
proteins, the largely uncharacterized suppressor of actin mutations
1-like SACM1L [37], modulated toxicity for all three damaging
agents. SACM1L is a phosphatase, regulating Golgi morphology
Figure 4. Autophagic response to MMS is modulated by ATP6V1D and ZFYVE20. A) Inhibition of autophagy further sensitizes the cells that
have been depleted of ZFYVE20 and APT6V1D to MMS. B) The formation of autophagosomes after MMS treatment is visible in a background of
cytoplasmic GFP. C) MMS induces autophagy in cells that is dependent on ZFYVE20. The statistical significance of the difference between each
condition and its untreated control is indicated by asterisks (* p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0037368.g004
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[38,39]; interestingly, deletion of the yeast homolog of this protein
caused cellular sensitivity to all four damaging agents tested in the
yeast screen [13].
One striking result of our study is that we have identified many
proteins that, when their mRNA levels are reduced, cause relative
resistance to the DNA damaging agents, even though the proteins
were selected based on the corresponding yeast deletion strains
being sensitive to the agents. This observation was particularly
noteworthy after exposure to 4-NQO for the members of histone
modifier complexes, RNF20, SIN3A, CDC40, topoisomerase
TOP3A and RNA polymerase subunit POLR2D. Possibly, this is
a reflection of differential maintenance of chromatin structure in
mammals versus S. cerevisiae. While the discrepancy is puzzling, it
has been shown previously that even within the same organism,
cells of different origin can display distinctive, even opposite,
phenotypes after being exposed to damaging agents [40,41,42,43].
One dramatic example is that while mouse ES cells deficient in the
Aag glycosylase are MMS sensitive, relative to WT, myeloid bone
marrow cells and retinal rods and cones deficient in the same
enzyme are extremely MMS resistant [43,44].
Vesicle transporters were among the unexpected toxicity-
modulators in the yeast gene deletion screen. The endosomal
vesicle transport, especially the late endosomal/lysosomal trans-
port, is used for degradation of biomaterial, a process that
intersects with the pathway of autophagy. This group of proteins is
highly conserved between yeast and humans. Interestingly, the
classical autophagy proteins (ATG1-ATG31) were not over-
represented among the sensitive yeast deletion strains, suggesting
an alternative autophagy-like path taken after treatment with
DNA damaging agents. Processing by autophagosomes/lysosomes
and proteasome are two ways to clear the cell of proteins and other
biomaterial. The autophagosomes can be generated from the
cytoplasm but can also be derived from the trans-Golgi, when cells
are exposed to the topoisomerase II inhibitor etoposide [45]. The
previously described role of autophagy in DNA damage response
has usually been linked to the cellular death program, as several
genotoxic agents have been shown to induce autophagic cell death
[46,47,48,49]. In contrast, this study suggests that cells escape cell
death by induction of autophagy, because when autophagy is
reduced, cells are more sensitive to MMS. This is supported by
other recent studies that show that damage can also lead to non-
lethal autophagy [45,50]. The study of autophagy is also important
from a clinical viewpoint because autophagy has been shown to
suppress tumorigenesis [51], as well as clearing cells that contain
protein aggregates such as those formed in Huntinton’s disease
[52].
Here, we have confirmed that telomere-specific proteins are
needed for cells to recover after treatment DNA damaging agents.
Telomere proteins in yeast are also involved in DNA damage
repair, but here we have shown that specific loss of telomere
maintenance, by reducing the protein levels of members of the
shelterin complex, results in sensitivity to alkylating damage. We
have also identified new toxicity-modulating proteins involved in
chromatin modification. Previously, it was known that another
Ada2-homolog, TADA2B a mammalian paralog of TADA2A, is
needed in the cellular response to UV irradiation. This adaptor
protein is part of the STAGA (homologous to SAGA in yeast)
histone acetylation complex and is required for transcription of
p53 responsive elements after UV [53,54]. TADA2A on the other
hand is a component of the similar histone acetylation complex
PCAF, whose activity was recently implicated in the p53 pathway
[55]. The Ada2 homologs have also been found in H2B
deubiquitination complexes. Ubiquitination of H2B is performed
by the ubiquitin ligase RNF20, also identified as a toxicity-
modulator in this study. Interestingly, a component involved in the
deubiquitination of H2B (TADAD2A) has the reverse toxicity-
modulation compared to an H2B ubiquitin ligase (RNF20). Other
studies have shown that depletion of RNF20 inhibits both G1
arrest and apoptosis, but stimulates tumor advancement; its
promotor is often hypermethylated in tumors [56,57]. Further,
RNF20 ser-522 has been identified as an ATM/ATR phosphor-
ylation substrate after exposure to ionizing radiation [57].
Depletion of the human RNF20 paralog RNF40 was recently
shown to stimulate cell growth and cell migration [58]. RNF20/
RNF40-mediated ubiquitination of H2B is a prerequisite for RNA
PolII transcription, possibly explaining the observed similarity in
toxicity-modulation between RNF20 and RNA PolII subunit D
(POLR2D) (Figure 2).
Conclusions
Based on yeast orthology and conserved network structures, we
have identified several human proteins necessary for recovery after
cellular damage, among them components of autophagy and
chromatin modifiers. Clearly, the functional relationships between
yeast and human homologs are complex as the lack of some
proteins conferred sensitivity in yeast cells but in human cells
resulted in resistance as compared to their WT counterparts.
Nevertheless, by studying the machinery that surrounds the core
DNA repair proteins, we obtain a better understanding of the way
cells respond to genotoxic insults. Most of the identified toxicity-
modulating proteins have not been linked to DNA repair, cell
cycle arrest or cell death and highlight the vast array of proteins
that are involved in damage recovery after exposure to DNA
damaging agents.
Materials and Methods
Bioinformatic analysis
Genome-wide yeast sensitivity data [13] was downloaded from
http://genomicphenotyping.mit.edu/source2.html. Human
orthologs to the yeast proteins were identified through Ensembl
and Inparanoid. Orthologues of S. cerevisiae genes of interest in
human, mouse, and yeast, were obtained from Ensembl49 (http://
ensembl.org/) [59]. A merged human interactome by A. Garrow,
Y. Adeleye and G. Warner [28] combines human interactions
reported in IntAct, DIP, BIND and HPRD, in addition to papers
by [60,61]. The interactome was queried using Cytoscape 2.6
(http://cytoscape.org).
Human expression data was used from [29]. Genes with
microarray expression values .100 were considered expressed.
Cell culture
293T cells (ICLC catalog code: HTL04001, [62]) and their
derivatives were cultured in Dulbecco’s minimal essential media
(Invitrogen) complemented with 10% fetal bovine serum, L-
glutamine, 1% penicillin, and streptomycin. shRNAs expressed in
a lentiviral plasmid (pGIPZ) were purchased from Open
Biosystems. Three to nine clones were analyzed for mRNA levels,
and the clone with the lowest residual mRNA concentration was
subsequently used. Identity of shRNAs and sequences of qRT-
PCR primers (Eurofin) are found in the Table S3. Knockdown
cells were compared with 293T cells expressing a non-targeting
shRNA (#RHS4346). Virus was generated in 293T cells using
packaging plasmids psPAX2, pMD2.G (Addgene plasmid 12260
and 12259). Parental cell lines were infected with virus and stable
clones selected using Puromycin (Invivogen). A few proteins were
targeted by multiple shRNA constructs. After shRNA infection,
most genes had residual levels below 30%, a few had 30–60%
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residual levels. For some targets, no reduction in mRNA levels
could be detected even though all target plasmids were in-
corporated into the parental cells, as determined by the co-
expression of GFP. Catalog numbers and primer sequences are
available in Table S3.
Colony forming assay
50–5,000 cells were seeded in 6-well plates and 16 hours later
cells were washed with PBS and exposed in duplicates to 4-NQO,
tBuOH, MMS (Sigma) in serum-free media. After one hour, drug-
containing media was replaced by complete media and incubated
for 6 days. Colonies were washed with cold PBS, dried overnight,
fixed and stained with 0.25% Methylene blue in ethanol and
counted.
Calculation of toxicity-modulation
For a protein to be called toxicity-modulating, the survival of its
corresponding cell line had to be significantly different from the
non-silencing control cells (p,0.05, t-test) and had to be at least
20% more sensitive or resistant (+/2 0.26 in log2-space) than any
of the control cells in the ‘noise region’ (the region created by the
boundaries of the cell lines without targeted knock-down) at at
least one dose-point. For a protein to be confer ‘high sensitivity’/
‘high resistance’, the cellular survival had exceed 25% (+/2 0.32
in log2-space) at – at least – one dose-point.
Autophagy detection
The plasmid EGFP-LC3 was purchased from Addgene (plasmid
11546) [63], and transfected into 293T cells. Autophagy was
inhibited by addition of 0.1 uM Bafilomycin A1 (B-1080 from LC
Laboratories, Woburn, MA) or 10 mM 3-Methyladenine (from
Sigma-Aldrich, Louisville) two hours prior to as well as during
treatment with the DNA damaging agent. For LysoTracker Red
staining, the cells were treated with 50 nM LysoTracker Red
DND-99 (Invitrogen) at 37uC for 30 min. Cells were fixed in 3.7%
formaldehyde, and nuclei were stained with Prolong Gold with
DAPI (Invitrogen).
Supporting Information
Figure S1 Survival of cell lines without significant RNA
reduction. A) mRNA levels of target transcripts that were not
significantly reduced (ns – non-silencing clone). B–C) Survival
curves of the control cell line expressing non-silencing shRNA
(black), four cell lines with non-significant reduction of levels of the
targeted RNA (grey), and additional cell lines with reduced levels
TMLHE (red), TADA2A (blue) and TERF2 (green) after
treatment with B) 4-NQO or C) MMS.
(TIF)
Figure S2 The survival of exposed WT cells is di-
minished after inhibition of autophagy. The cells were
exposed to A) 4-NQO, and B) tBuOOH.
(TIF)
Table S1 GO terms enriched in networks of toxicity
modulating proteins. Enrichment in human cells (S1a) is
contrasted with yeast cells (S1b).
(PDF)
Table S2 Summary of the human potential toxicity-
modulating proteins. The summary includes the described
function in the cell and the yeast homologs, together with
a toxicity-modulation summary of both yeast and human cells.
(PDF)
Table S3 shRNA constructs and qRT-PCR primers.
(PDF)
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